학술논문
Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growth
Document Type
Article
Author
Source
In: Scientific Reports . (Scientific Reports, December 2023, 13(1))
Subject
Language
English
ISSN
20452322